Optical Coherence Tomography Angiography (OCTA) Changes in Patients With Epiretinal Membranes (ERM) With and Without Peeling of the Internal Limiting Membrane (ILM)
NCT05287009 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2022-03-31
Summary
Main objective
The objective is to compare two surgical options in vitrectomies for epiretinal membranes using parameters of optical coherence tomography angiography.
Background
State of the art treatment for epiretinal membranes consists of pars plana vitrectomy, staining of the epiretinal membrane with a blue colouring dye and epiretinal membrane peeling. The vitrectomized space is filled with fluid (balanced salt solution) during the procedure and the fluid can optionally be replaced with air as a final step. After ERM peeling (but before the selection of the tamponade), the internal limiting membrane (the innermost layer of the retina) is either peeled as well or left untouched and the question which method should be preferred has been a hot topic in recent years. The investigators want to investigate possible effects of the used method (peeling vs. nonpeeling) on retinal perfusion parameters represented by OCTA. Two epiretinal membrane patient groups will therefore be formed: The first group's (group 1) ILM will be peeled, the second group's (group 2) ILM will not be peeled. After recruitement, patients will therefore be electronically randomized to one of the two groups. The groups will then be compared by the means of OCTA.
Study design
* Since there are no previous data on our research question, this investigation is defined as a pilot study.
* 40 patients with epiretinal membranes will be included. This appears to be a reasonable number given the incidence of epiretinal membranes. Previous studies that compared peeling versus nonpeeling in ERM used similar sample sizes. The detectable effect size was calculated at d = 0.91. We intend to complete this pilot study within 9 months.
* Randomization will be performed using electronic randomization. 20 patients each will be randomized to either group 1 or group 2.
* Both eyes in each patient will be imaged.
* No treatment decisions will be made based on OCTA findings. Treatment decisions will be made according to the clinic's standard of care.
* Three follow-up visits specific to the study are needed. These visits will be scheduled one week, one month and three months after surgery. All other preoperative and follow-up visits will be decided by the treating physician and follow the clinic standard of care.
Examinations
* Distance visual acuity using ETDRS (Early Treatment Diabetic Retinopathy Study) standard at 4 meters as per clinic standard of care.
* Tonometry as per clinic standard of care.
* Slit-lamp evaluation as per clinic standard of care.
* Arterial blood pressure.
* Axial eye length.
* Heidelberg Spectralis conventional OCT.
* The following 2 AngioVue scans will be taken:
A. One 3mm x 3mm, 304 x 304 A-scan OCTA of the macula B. One 6mm x 6mm, 304 x 304 A-scan OCTA of the macula
Hypothesis
The null hypothesis of our investigation indicates that there are no statistically significant differences in OCTA perfusion parameters based on the used option.
The alternative hypothesis states that there are statistically significant differences in OCTA perfusion parameters based on the used option.
Primary Objective
To demonstrate possible differences in OCTA perfusion parameters based on the used option.
Secondary Objectives
To assess the feasibility of the AngioVue optical coherence tomography angiography system in evaluating subtle changes in the retinal perfusion of patients with epiretinal membranes.
Conditions
- Epiretinal Membrane of Both Eyes
Interventions
- PROCEDURE
-
ILM nonpeeling
ILM is not peeled after ERM removal
- PROCEDURE
-
ILM peeling
ILM is peeled after ERM removal
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-25
- Primary Completion
- 2022-03-09
- Completion
- 2022-03-09
Countries
- Austria
Study Locations
More Related Trials
-
Comparison of Two Techniques for Epiretinal or Internal Limiting Membrane Peel
NCT00892619 ·Status: UNKNOWN ·Phase: NA
-
Post-surgical Functional Results in Patients With Epiretinal Membrane Undergoing Controlled Macular Detachment
NCT07095907 ·Status: RECRUITING ·Phase: NA
-
Clinical Evaluation of With or Without Internal Limiting Membrane Peeling for Idiopathic Epiretinal Membrane Surgery: A Randomized Controlled Trial
NCT07142785 ·Status: RECRUITING ·Phase: NA
-
Choroidal Thickness Vitrectomy
NCT02617147 ·Status: COMPLETED
-
Inverted Internal Limiting Membrane Flap Technique for Macular Hole Retinal Detachment in Highly Myopic Eyes
NCT02896972 ·Status: COMPLETED ·Phase: NA
-
Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery
NCT04130841 ·Status: UNKNOWN ·Phase: NA
-
Visual Acuity and Optical Coherence Tomography One Year After ILM-flap Transposition
NCT03465865 ·Status: COMPLETED
-
Fourier Transformed Infrared Spectroscopy in Macular Surgery
NCT03452748 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Multifocal ERG and Visual Field Changes After Vitrectomy and ILM Peeling
NCT04281173 ·Status: UNKNOWN
-
" Sweeper " and Epiretinal Membrane Surgery
NCT03350607 ·Status: COMPLETED
-
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
NCT05145491 ·Status: RECRUITING ·Phase: NA
-
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy
NCT04380064 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Foveal Sparing ILM Peeling With ILM Flap Transposition
NCT05897671 ·Status: COMPLETED
-
ILM Peeling in PDR Patients Undergoing PPV for VH
NCT03660371 ·Status: COMPLETED ·Phase: NA
-
UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue
NCT00437593 ·Status: COMPLETED ·Phase: NA
-
Cultivation of Hyalocytes From ILM and ERM Samples: a Pilot Study
NCT04306718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap Technique
NCT04883697 ·Status: COMPLETED
-
Comparision of Retinal Function and Macular Structure After 27G Pars Plana Vitrectomy With Minimal Illuminiation
NCT06798285 ·Status: COMPLETED ·Phase: NA
-
Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
NCT04278079 ·Status: COMPLETED ·Phase: NA
-
Tilt of the Intraocular Lens in Patients Undergoing Combined Phacoemulsification and Vitrectomy With Airtamponade
NCT03372759 ·Status: COMPLETED ·Phase: NA
-
Observational Study - ILM Peeling
NCT01083056 ·Status: COMPLETED
-
Fovea ERM After Fovea-sparing ILM Peeling
NCT04445142 ·Status: COMPLETED
-
Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling
NCT04472039 ·Status: COMPLETED
-
Foveal Sparing of the ILM
NCT03488576 ·Status: COMPLETED ·Phase: NA
-
Internal Limiting Membrane Peeling for Large Macular Holes
NCT00190190 ·Status: COMPLETED ·Phase: NA